Funding for rare disease treatment at Centres of Excellence has significantly dropped, with allocations falling from Rs 82.87 crore to Rs 32.73 crore. Despite this, many institutions report unspent funds, indicating issues with fund utilization and patient support, even as new releases are limited.
